BioSpace News Archive

Layoffs

Rocket Trims Headcount and Pipeline Focus Amid Clinical, Regulatory Turbulence

The strategic reprioritization comes after the company hit two major hurdles in the past year, including a clinical hold for an investigational gene therapy and an FDA rejection for its lead asset.

July 25, 2025

·

2 min read

·

Tristan Manalac

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

Adicet’s Pipeline Optimization Push Claims 30% of Workforce

Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.

July 25, 2025

·

168 min read

·

BioSpace Editorial Staff

Dollars as a global currency, loan, credit, and payment concept. A hand offering 100 US dollars. Minimalist art collage

Collaboration

Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines

The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.

July 25, 2025

·

1 min read

·

Dan Samorodnitsky

Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.

Regulatory

Sarepta Fallout Continues With EU’s Negative Opinion of Elevidys in Ambulatory Patients

The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne muscular dystrophy.

July 25, 2025

·

2 min read

·

Tristan Manalac

Problems and Challenges. Businessman stands on question mark

Gene therapy

Sarepta’s Future Increasingly Uncertain as FDA Eyes New Study for Elevidys

CBER is unanimously against Elevdiys’ return to the market without additional evidence, according to media reports citing an anonymous senior FDA official. Given Elevidys’ full approval, however, experts told BioSpace this path would set up a length legal battle between the regulator and Sarepta Therapeutics.

July 25, 2025

·

4 min read

·

Tristan Manalac

Press Releases

Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

July 25, 2025

·

10 min read

Press Releases

Almirall H1 2025 Results